Follow The Filings

QXL Quantum X Labs

Quantum X Labs earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -0.59 —
Rev — — —

Insider trades

Open-market buys and sales by QXL's executives, directors and 10% owners in the last 12 months, from their Form 4s

All QXL insider trades
  • $46K bought by 2 insiders
  • $61K sold by 1 insider outside a trading plan
  • None no planned (10b5-1) sales
  1. Yakov Baranes CEO
    Buy
    $24K 5,000 shares at $4.88 +1.4% to stake
    Traded Sep 15 Filed Sep 17
    ↗
  2. Eliyahu Yoresh Director
    Buy
    $21K 4,500 shares at $4.77 +179% to stake
    Traded Aug 21 Filed Aug 24
    ↗
  3. Amitay Weiss Director
    Sale
    $61K 30,296 shares at $2.00 100% of stake
    Traded Mar 31 Filed Apr 1
    ↗
  4. Eliyahu Yoresh Director
    Buy
    — 179,159 shares +107% to stake
    Traded Mar 4 Filed Mar 12
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 option exercises.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.02,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 5.03,7.01,8.01,9.01 Filing Doc
8-K 7.01,8.01,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G — Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
8-K 8.01 Filing Doc
10-Q Filing Doc
8-K 1.01 Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.